Attached files
EXHIBIT
32
SECTION
1350 CERTIFICATION
In
connection with the Quarterly Report of Guided Therapeutics, Inc.
(the "Company") on Form 10-Q for the quarter ended March 31, 2020, as filed with the
Securities and Exchange Commission on the date hereof (the
"Report"), I, Gene S. Cartwright, President, Chief Executive
Officer and acting Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to
Sec 906 of the Sarbanes-Oxley Act of 2002, that to the best of
my knowledge and belief:
(1)
|
the
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
the
information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
|
Date:
July 6, 2020
|
_/s/
Gene S. Cartwright
|
|
|
Name: Gene
S. Cartwright
|
|
|
Title: President,
Chief Executive Officer and acting Chief Financial
Officer
|
|
|
|
|